stockrow
Friday 6 November 2026
Export CAH’s income statement to Excel — free account
Cardinal Health, Inc.
CAH Healthcare Medical Distribution
Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025.
- Revenue
- +5.47%
- EPS
- +26.3%
- Free cash flow
- +10.9%
- Total debt
- −2.40%
Quarter to September 2026, against a year earlier
267.66
5.73
+2.19%
Follow CAH
Alert me
| Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 | Jun '20 | Jun '19 | Jun '18 | Jun '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
7 | 6 | 6 | 7 | 5 | 8 | 6 | 7 | 6 | 4 |
P/E ratio |
32.72 | 25.93 | 28.62 | 93.63 | 0.00 | 27.32 | 0.00 | 10.50 | 64.67 | 19.15 |
Altman Z-Score |
5.09 | 4.73 | 5.39 | 5.08 | 4.34 | 4.05 | 3.76 | 4.20 | 3.92 | 4.25 |
P/S ratio |
0.22 | 0.18 | 0.11 | 0.12 | 0.08 | 0.10 | 0.10 | 0.10 | 0.11 | 0.19 |
Altman Z″-Score (non-manufacturers) |
(0.22) | (0.03) | (0.02) | 0.00 | 0.23 | 0.71 | (0.16) | 1.22 | 0.86 | 2.14 |
P/FCF ratio |
12.31 | 21.85 | 7.34 | 10.45 | 5.17 | 8.22 | 9.64 | 5.96 | 6.45 | 30.99 |
P/Operating CF |
33.13 | 26.64 | 11.50 | 28.60 | 4.79 | 25.07 | 63.72 | 28.20 | 27.77 | 34.12 |
Beneish M-Score |
(2.74) | (2.32) | (2.67) | (2.74) | (2.77) | (2.59) | (3.11) | (2.50) | (2.74) | (2.44) |
Dividend Safety Score |
86 | — | — | — | — | — | — | — | — | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.29 | 8.53 | 2.25 | 2.54 | 3.62 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.24 | 0.20 | 0.11 | 0.12 | 0.08 | 0.12 | 0.13 | 0.14 | 0.17 | 0.22 |
EV/EBITDA |
16.84 | 14.73 | 12.24 | 17.53 | 178.60 | 15.54 | 0.00 | 6.46 | 19.55 | 9.95 |
EV/Operating CF |
11.61 | 18.83 | 6.36 | 8.90 | 4.78 | 8.03 | 9.84 | 7.26 | 8.18 | 23.83 |
EV/FCF |
13.19 | 24.36 | 7.33 | 10.71 | 5.39 | 9.61 | 12.16 | 8.26 | 9.49 | 35.40 |
Quick Ratio |
0.43 | 0.44 | 0.48 | 0.45 | 0.50 | 0.45 | 0.47 | 0.46 | 0.42 | 0.70 |
Current Ratio |
0.88 | 0.94 | 0.98 | 1.00 | 1.08 | 1.12 | 1.10 | 1.07 | 1.07 | 1.34 |
Net Debt/EBITDA |
1.13 | 1.52 | (0.02) | 0.43 | 7.04 | 2.25 | (1.26) | 1.80 | 6.26 | 1.24 |
Debt/Assets |
15.51% | 16.05% | 11.29% | 10.84% | 12.11% | 14.03% | 16.62% | 19.61% | 22.56% | 25.91% |
Debt/Equity |
(3.26) | (3.24) | (1.59) | (1.59) | (7.53) | 3.48 | 3.78 | 1.27 | 1.49 | 1.52 |
Asset Turnover |
4.61 | 4.53 | 5.13 | 4.70 | 4.11 | 3.81 | 3.74 | 3.60 | 3.42 | 3.50 |
Operating CF/Net income |
3.02 | 1.54 | 4.42 | 8.62 | (3.38) | 3.98 | (0.53) | 2.00 | 10.81 | 0.92 |
Capex/Depreciation |
(0.65) | (0.69) | (0.70) | (0.70) | (0.51) | (0.51) | (0.41) | (0.33) | (0.37) | (0.54) |
Interest Coverage |
7.51 | 10.58 | 24.37 | 8.95 | (4.13) | 2.62 | (17.22) | 7.01 | 0.38 | 10.55 |
| (63.98%) | (53.40%) | (27.62%) | (18.02%) | (172.43%) | 34.08% | (91.01%) | 22.00% | 3.97% | 19.23% | |
| 3.10% | 3.18% | 1.93% | 0.76% | (2.12%) | 1.43% | (9.04%) | 3.37% | 0.64% | 3.47% | |
ROIC |
125.05% | 70.42% | 0.00% | 0.00% | 0.00% | 6.38% | (44.19%) | 10.88% | 0.59% | 12.81% |
Return on Tangible Assets |
(80.85%) | 467.37% | 48.05% | 13.43% | (19.76%) | 10.56% | (78.79%) | 34.13% | 6.17% | 14.31% |
Average Days of Receivables |
19.83 | 21.72 | 19.45 | 19.78 | 21.26 | 20.45 | 19.72 | 21.19 | 20.81 | 22.60 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
2.52% | 2.47% | 2.20% | 2.34% | 2.49% | 2.79% | 2.99% | 3.08% | 3.36% | 2.90% |
Intangible Assets out of Total Assets |
0.24 | 0.23 | 0.14 | 0.14 | 0.17 | 0.23 | 0.28 | 0.29 | 0.31 | 0.23 |
Share Based Compensation of Revenue |
0.14% | 0.11% | 0.05% | 0.05% | 0.04% | 0.05% | 0.06% | 0.06% | 0.06% | 0.07% |
Graham Net Nets |
(0.38) | (0.48) | (0.56) | (0.51) | (0.80) | (0.70) | (0.85) | (0.62) | (0.61) | (0.20) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 13.98 | 17.00 | 0.00 | 46.37 | 18.19 | 44.41 |
Earnings Yield |
3.06% | 3.86% | 3.49% | 1.07% | (6.57%) | 3.66% | (23.86%) | 9.52% | 1.55% | 5.22% |
Free Cash Flow Yield |
8.13% | 4.58% | 13.62% | 9.57% | 19.33% | 12.17% | 10.38% | 16.78% | 15.50% | 3.23% |
Revenue per Share |
1,077.32 | 923.56 | 925.82 | 785.36 | 649.91 | 556.39 | 521.92 | 485.11 | 437.09 | 410.02 |
Operating CF per Share |
21.92 | 9.95 | 15.36 | 10.90 | 11.38 | 8.32 | 6.69 | 9.07 | 8.84 | 3.74 |
Capex per Share |
(2.62) | (2.26) | (2.04) | (1.84) | (1.28) | (1.37) | (1.27) | (1.09) | (1.23) | (1.22) |
Free Cash Flow per Share |
19.31 | 7.69 | 13.32 | 9.05 | 10.10 | 6.95 | 5.42 | 7.98 | 7.62 | 2.51 |
Cash per Share |
20.58 | 16.07 | 20.95 | 15.62 | 16.91 | 11.67 | 9.46 | 8.44 | 5.63 | 21.70 |
Shareholders Equity per Share |
(11.54) | (10.93) | (13.11) | (11.33) | (2.53) | 6.14 | 6.12 | 21.10 | 19.36 | 21.54 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(11.54) | (10.93) | (13.11) | (11.33) | (2.53) | 6.14 | 6.12 | 21.10 | 19.36 | 21.54 |
Free Cash Flow |
4,556.00 | 1,853.00 | 3,263.00 | 2,363.00 | 2,819.00 | 2,029.00 | 1,587.00 | 2,394.00 | 2,384.00 | 797.00 |
Working Capital |
(5,151.00) | (2,524.00) | (756.00) | (3.00) | 2,385.00 | 3,424.00 | 2,325.00 | 1,638.00 | 1,660.00 | 7,124.00 |
Capital Expenditures |
(618.00) | (544.00) | (499.00) | (481.00) | (356.00) | (400.00) | (373.00) | (328.00) | (384.00) | (387.00) |
Net Current Asset Value |
(21,270.00) | (19,383.00) | (13,449.00) | (12,569.00) | (11,649.00) | (11,611.00) | (13,034.00) | (8,886.00) | (9,339.00) | (4,939.00) |
EV/EBIT |
23.00 | 19.84 | 19.24 | 33.65 | 0.00 | 41.31 | 0.00 | 9.60 | 179.63 | 13.31 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
21.46 | 17.80 | 19.27 | 32.82 | 0.00 | 35.32 | 0.00 | 6.93 | 122.09 | 11.65 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.32 | 0.28 | 0.28 | 0.28 | 0.29 | 0.33 | 0.39 | 0.42 | 0.42 | 0.38 |
Cash ROIC |
41.35% | 18.97% | 46.53% | 40.60% | 30.23% | 17.74% | 14.00% | 14.17% | 14.16% | 3.31% |
Accounts Receivable Turnover |
18.79 | 17.58 | 19.56 | 18.92 | 18.44 | 18.71 | 18.30 | 17.91 | 17.27 | 16.82 |
Accounts Payable Turnover |
6.70 | 6.45 | 7.11 | 6.94 | 6.88 | 6.91 | 6.81 | 6.73 | 6.90 | 7.01 |
Inventory Turnover |
14.33 | 13.49 | 14.12 | 12.48 | 11.57 | 11.20 | 11.23 | 11.04 | 10.98 | 11.26 |
Average Days of Payables |
57.16 | 59.09 | 52.83 | 55.15 | 56.63 | 55.56 | 53.42 | 56.67 | 55.41 | 52.95 |
Days of Inventory on Hand |
25.82 | 28.65 | 24.88 | 29.70 | 32.64 | 34.21 | 32.98 | 33.74 | 34.66 | 33.42 |
Average Receivables |
13,528.50 | 12,663.00 | 11,596.00 | 10,834.50 | 9,832.00 | 8,683.50 | 8,356.00 | 8,124.00 | 7,924.00 | 7,726.50 |
Average Payables |
36,498.00 | 33,236.00 | 30,846.50 | 28,531.00 | 25,414.00 | 22,537.00 | 21,454.50 | 20,606.00 | 18,791.50 | 17,606.00 |
Average Inventory |
17,064.00 | 15,894.00 | 15,538.00 | 15,877.50 | 15,115.00 | 13,896.00 | 13,010.00 | 12,565.00 | 11,804.50 | 10,958.00 |
Average Assets |
55,210.50 | 49,121.50 | 44,235.00 | 43,613.50 | 44,165.50 | 42,609.50 | 40,864.50 | 40,457.00 | 40,031.50 | 37,117.00 |
Average Common Equity |
(2,679.00) | (2,923.00) | (3,084.50) | (1,831.50) | 544.00 | 1,793.00 | 4,061.00 | 6,194.50 | 6,443.50 | 6,699.50 |
Columns are period end dates · fundamentals updated 5 Nov 2026